Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Gains from Investment Securities (2019 - 2022)

RedHill Biopharma has reported Gains from Investment Securities over the past 4 years, most recently at $823000.0 for Q4 2022.

  • Quarterly Gains from Investment Securities rose 1103.66% to $823000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2022, up 443.77% year-over-year, with the annual reading at $1.0 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities was $823000.0 for Q4 2022 at RedHill Biopharma, down from $4.8 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $4.8 million in Q1 2022 and troughed at -$82000.0 in Q4 2021.
  • The 4-year median for Gains from Investment Securities is $630000.0 (2020), against an average of $1.1 million.
  • Year-over-year, Gains from Investment Securities crashed 142.71% in 2021 and then surged 1103.66% in 2022.
  • A 4-year view of Gains from Investment Securities shows it stood at $124000.0 in 2019, then surged by 54.84% to $192000.0 in 2020, then plummeted by 142.71% to -$82000.0 in 2021, then surged by 1103.66% to $823000.0 in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Gains from Investment Securities are $823000.0 (Q4 2022), $4.8 million (Q1 2022), and -$82000.0 (Q4 2021).